Recall Register

Food, drugs, devices › NeuroLogica Corporation

Device recall: Solid state x-ray imager (flat panel/digital imager) Solid state x-ray imager (flat panel/digital imager) Medical

FDA enforcement event 79628 · Class II · initiated 12 Jan 2018 · status Terminated · terminated 14 Aug 2018

DeviceVoluntary: Firm initiated1 product recordDanvers, MA

FDA enforcement event 79628 is a device recall by NeuroLogica Corporation of Danvers, MA, initiated 12 Jan 2018 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 92% of the 1,074 device enforcement events initiated in 2018 carry the same class.

Status: Terminated, terminated 14 Aug 2018. Initiation: voluntary: firm initiated. NeuroLogica Corporation has 12 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

NeuroLogica Corporation, Danvers, MA.

Reason for recall

"While transporting the portable machine with the retrofit equipment in a backwards motion, there is potential for foot injury from the underside of the detector bin of the retrofit unit."

Distribution

"US Distribution . Only one consignee was shipped 16 units of the affected device."

Product records

Recall numberProductQuantityClassStatusReport date
Z-1391-2018Solid state x-ray imager (flat panel/digital imager) Solid state x-ray imager (flat panel/digital imager) Medical16 unitsClass IITerminated25 Apr 2018

Context

92%of 2018 device events are Class II1,074 events that year
1product record in this eventfirm median: 1
12events on this register for the firm

Other enforcement events for NeuroLogica Corporation

InitiatedProduct (first record)TypeClassRecords
7 Oct 2025GM85 Digital Mobile X-ray imaging System; Model Number: GM85;DeviceClass II1
8 Jul 2024GM60A. Digital Diagnostic Mobile X-Ray System.DeviceClass II1
28 Dec 2023Samsung Digital Diagnostic Mobile X-ray System, Model GM85.DeviceClass II1
6 Jun 2023OmniTom/OmniTom Elite- X-ray computed tomography applications for anatomy that can be imaged in the 40 cm aperture, primDeviceClass II1
8 Mar 2023Samsung GM85 Digital X-ray Imaging System-A Digital Diagnostic Mobile X-ray SystemDeviceClass II1
15 Jul 2020OmniTom Computed tomography x-ray system, Model NL5000, all NL5000 systems with software version before 05.01.01 - ProduDeviceClass II1
25 Jul 2019HS70A Diagnostic Ultrasound System Version 2.01.00, 2.01.01, 2.01.02, 2.01.03, 2.01.04, 2.01.05, 2.01.06, 1.00.06, 1.00.DeviceClass II2
6 May 2019Samsung GM85 Mobile Digital X-ray Imaging System Product Usage: The GM85 Digital X-ray imaging System is intended for usDeviceClass II1
22 Jun 2017The GC80 Digital X-ray Imaging SystemDeviceClass II1
24 May 2017Samsung GU60A system- Digital X-ray Imaging Systems are intended for use in generating radiographic images of human anatDeviceClass II1

All 12 events for NeuroLogica Corporation

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "While transporting the portable machine with the retrofit equipment in a backwards motion, there is potential for foot injury from the underside of the detector bin of the retrofit unit."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Distribution . Only one consignee was shipped 16 units of the affected device."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 14 Aug 2018. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.